Tumour necrosis factor-alpha (TNF) has been regarded as a potential mediator of cancer cachexia. Assessment of TNF circulating levels in cancer patients and their correlation with weight loss has led to controversial results
PubMedID: 7978027Purpose: Tumor necrosis factor (TNF)-? is a multifunctional cytokine that influence...
Rats bearing the Yoshida AH-130 ascites hepatoma showed enhanced fractional rates of protein degrada...
BACKGROUND: Weight loss is recognised as a marker of poor prognosis in patients with cancer but the ...
The weight loss and metabolic alterations induced by human recombinant tumour necrosis factor-alpha ...
Leptin is a recently identified hormone produced by the adipocyte ob gene which acts as a negative f...
Cancer cachexia is a multifaceted syndrome whose aetiology is extremely complex and is directly rela...
One of the major complications found in patients affected by malignancy of the gastrointestinal trac...
SUMMARY. Fasting blood samples were collected from 83 patients with histologically proven breast can...
Fat loss is associated with shorter survival and reduced quality of life in cancer patients. Effect...
Patients with advanced cancer and cachexia typically demonstrate modestly increased rates of energy ...
AbstractTumour necrosis factor-α (TNF) is a pleiotropic cytokine involved in many metabolic response...
TNF, a key role in obesity?Tumour necrosis factor-K (TNF) is a pleiotropic cytokine involved in many...
Chronic systemic inflammatory response is proposed as an underlying mechanism for development of can...
Abstract Background Cancer‐associated wasting, termed cancer cachexia, has a profound effect on the ...
Reduced food intake is a major cause of continuing weight loss in patients with cancer. Previous wor...
PubMedID: 7978027Purpose: Tumor necrosis factor (TNF)-? is a multifunctional cytokine that influence...
Rats bearing the Yoshida AH-130 ascites hepatoma showed enhanced fractional rates of protein degrada...
BACKGROUND: Weight loss is recognised as a marker of poor prognosis in patients with cancer but the ...
The weight loss and metabolic alterations induced by human recombinant tumour necrosis factor-alpha ...
Leptin is a recently identified hormone produced by the adipocyte ob gene which acts as a negative f...
Cancer cachexia is a multifaceted syndrome whose aetiology is extremely complex and is directly rela...
One of the major complications found in patients affected by malignancy of the gastrointestinal trac...
SUMMARY. Fasting blood samples were collected from 83 patients with histologically proven breast can...
Fat loss is associated with shorter survival and reduced quality of life in cancer patients. Effect...
Patients with advanced cancer and cachexia typically demonstrate modestly increased rates of energy ...
AbstractTumour necrosis factor-α (TNF) is a pleiotropic cytokine involved in many metabolic response...
TNF, a key role in obesity?Tumour necrosis factor-K (TNF) is a pleiotropic cytokine involved in many...
Chronic systemic inflammatory response is proposed as an underlying mechanism for development of can...
Abstract Background Cancer‐associated wasting, termed cancer cachexia, has a profound effect on the ...
Reduced food intake is a major cause of continuing weight loss in patients with cancer. Previous wor...
PubMedID: 7978027Purpose: Tumor necrosis factor (TNF)-? is a multifunctional cytokine that influence...
Rats bearing the Yoshida AH-130 ascites hepatoma showed enhanced fractional rates of protein degrada...
BACKGROUND: Weight loss is recognised as a marker of poor prognosis in patients with cancer but the ...